Nirma to raise Rs 3,500 cr via bonds, pay upto 8.5%
Nirma entered into a deal with listed Glenmark Pharmaceuticals in September 2023 to buy a 75% stake in Glenmark Life Sciences for ₹5,650 crore. Nirma plans to fund the acquisition by the end of the current fiscal year.
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
